Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: a protocol for a randomised, placebo-controlled, double-blind feasibility trial—Optimising health outcomes with Metformin to prevent diAbetes After pregnancy (OMAhA)

Affiliations

• ¹ Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK [email protected].
• ² Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
• ³ Department of Family Care and Mental Health, University of Greenwich, London, UK.
• ⁴ Department of Statistics and Operational Research, Complutense University of Madrid, Madrid, Spain.
• ⁵ Institute for Health and Human Development, University of East London, London, UK.
• ⁶ Collaborations for Leadership in Applied Health Research and Care (CLAHRC) for North Thames London, Department of Applied Health Research, University College London, London, UK.
• ⁷ Women's and Children's Health, Royal London Hospital, Barts Health NHS Trust, London, UK.
• ⁸ Clinical Effectiveness Group, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
• ⁹ Women's Division, Royal London Hospital, Barts Health NHS Trust, London, UK.
• ¹⁰ Clinical Biostatistics Unit (IRYCIS) and CIBER Epidemiology and Public Health, Ramon y Cajal University Hospital, Madrid, Spain.
• ¹¹ Department of Statistics and Data Sciences, Complutense University of Madrid, Madrid, Spain.
• ¹² Department of Diabetes and Metabolism, Barts Health NHS Trust, Royal London Hospital, London, UK.
• ¹³ Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.